Plus Therapeutics is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system. The company’s technology combines image-guided local beta radiation and targeted drug delivery approaches to treat recurrent glioblastoma (GBM) and leptomeningeal metastases (LM).
